3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other neoplasm
1
Gynecologic
1
Conditions
Prostatic Neoplasms
15
Carcinoma, Non-Small-Cell Lung
9
Uterine Cervical Neoplasms
7
Colonic Neoplasms
6
Breast Neoplasms
5
Uterine Cervical Dysplasia
4
Urinary Bladder Neoplasms
4
Papillomavirus Infections
3
Neuroblastoma
3
Melanoma
3
Lung Neoplasms
3
Leukemia, Myeloid, Acute
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Anus Neoplasms
3
Triple Negative Breast Neoplasms
2
Thyroid Neoplasms
2
Squamous Intraepithelial Lesions
2
Rectal Neoplasms
2
Precancerous Conditions
2
Oropharyngeal Neoplasms
2
Neoplasms
2
Mouth Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Liver Neoplasms
2
Leukemia, Myelomonocytic, Acute
2
Leukemia, Monocytic, Acute
2
Leukemia, Megakaryoblastic, Acute
2
Leukemia, Erythroblastic, Acute
2
HIV Infections
2
Interventions
Carboplatin
5
Paclitaxel
4
pembrolizumab
3
Educational Status
3
niraparib
2
anlotinib
2
Therapeutic Touch
2
Pemetrexed
2
Palliative Care
2
Nivolumab
2
Methods
2
Gemcitabine
2
Early Intervention, Educational
2
Bevacizumab
2
temsirolimus
1
rucaparib
1
relacorilant
1
olaparib
1
nintedanib
1
nilotinib
1
liposomal doxorubicin
1
lenvatinib
1
fosaprepitant
1
atezolizumab
1
argatroban
1
Watchful Waiting
1
Transurethral Resection of Prostate
1
Topotecan
1
Thrombopoietin
1
Surveys and Questionnaires
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Genital Neoplasms, Female
×
Watchful Waiting
×
Clear all
NCT06815939
2026-01-29
OPTICS
DL Analytics
Phase NA
Recruiting
10,000 enrolled